MHRN Research Projects

Listed below are the research projects affiliated with, or supported by, MHRN funding.

Treatment Utilization Before Suicide

PI: Brian Ahmedani, PhD; Henry Ford Health System Research Centers

Suicide Supplement: Development of a Population-Based Risk Calculator for Suicidal Behavior

PI: Greg Simon, MD MPH; Kaiser Permanente Washington Health Research Institute

Safer Use of Antipsychotics in Youth (SUAY)

PI: Robert Penfold, PhD; Kaiser Permanente Washington Health Research Institute

Reducing Excess Cardiovascular Risk in People with Serious Mental Illness

PI: Rebecca Rossom, MD; Health Partners Institute

Precursors of first-episode psychosis in a population-based sample

PI: Gregory Simon, MD MPH; Kaiser Permanente Washington Health Research Institute

Pragmatic Trial of Population-based Programs to Prevent Suicide Attempt

PI: Greg Simon, MD; Kaiser Permanente Washington Health Research Institute

Practice Variation in High- and Low-value Care for Mood Disorders

PI: Gregory Simon, MD MPH; Kaiser Permanente Washington Health Research Institute

Pathways from Chronic Prescription Opioid Use to New Onset Mood Disorder

PI: Jeffrey F. Scherrer, PhD; Saint Louis University School of Medicine

Next Generation Assessment Using Mobile Devices

PI: Gregory Clarke, PhD; Kaiser Permanente Northwest

Maximizing Biospecimen Collection for Childhood Disorders

PI: Lisa Croen, PhD; Kaiser Permanente Northern California

Firearms means restriction for suicide prevention in pediatric primary care

PI: Rinad Beidas, PhD; University of Pennsylvania

FDA Black Box Warning and Suicide

PI: Stephen Soumerai, ScD; Harvard Pilgrim Health Care

Evaluating the Impact of Changes in Opioid Prescribing across Health Systems Implementing Zero Suicide

PI: Brian Ahmedani PhD (Contact PI); Henry Ford Health System

Effects of Medical Products on Suicidal Ideation and Behavior

PI: Gregory Simon, MD, MPH; KP Washington Health Research Institute

Diversity Supplement – Understanding factors that lead to disparities in depression treatment

PI: Karen J Coleman, PhD; Kaiser Permanente Southern California

Developing Tools to Evaluate the Impact of Safety Planning and Lethal Means Assessment on Suicide Outcomes

PI: Brian Ahmedani PhD; Henry Ford Health System

Computational Modeling of Suicide Risk

PI: Gregory Simon, MD, MPH; KP Washington Health Research Institute

Comparative Risks and Benefits of Gender Reassignment Therapies

PI: Michael Goodman, MD MPH; Emory University

Care of Mental, Physical and Substance Use Syndromes (COMPASS)

PI: Sanne Magnan, MD PhD; HealthPartners Institute

Behavioral Activation for Perinatal Depression

PI: Arne Beck, PhD; Kaiser Permanente Colorado

Automated Virtual Follow-Up to Reduce Premature Treatment Discontinuation

PI: Robert Penfold, PhD; Kaiser Permanente Washington Health Research Institute

Autism Registry

PI: Lisa Croen, PhD; Kaiser Permanente Northern California

An Evaluation of the Zero Suicide Model Across Learning Healthcare Systems

PI: Brian Ahmedani PhD (Contact PI); Henry Ford Health System